International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Kumar, Shaji, Prof, Paiva, Bruno, PhD, Anderson, Kenneth C, Prof, Durie, Brian, Prof, Landgren, Ola, MD, Moreau, Philippe, Prof, Munshi, Nikhil, Prof, Lonial, Sagar, MD, Bladé, Joan, Prof, Mateos, Maria-Victoria, Prof, Dimopoulos, Meletios, Prof MD, Kastritis, Efstathios, MD, Boccadoro, Mario, Prof, Orlowski, Robert, Prof, Goldschmidt, Hartmut, Prof, Spencer, Andrew, Prof, Hou, Jian, Prof, Chng, Wee Joo, Prof, Usmani, Saad Z, MD, Zamagni, Elena, MD, Shimizu, Kazuyuki, Prof, Jagannath, Sundar, Prof, Johnsen, Hans E, Prof, Terpos, Evangelos, MD, Reiman, Anthony, Prof, Kyle, Robert A, Prof, Sonneveld, Pieter, Prof, Richardson, Paul G, Prof, McCarthy, Philip, Prof, Ludwig, Heinz, Prof, Chen, Wenming, Prof, Cavo, Michele, Prof, Harousseau, Jean-Luc, Prof, Lentzsch, Suzanne, Prof, Hillengass, Jens, MD, Palumbo, Antonio, Prof, Orfao, Alberto, Prof, Rajkumar, S Vincent, Prof, Miguel, Jesus San, Prof, Avet-Loiseau, Herve, Prof
Published in The lancet oncology (01.08.2016)
Published in The lancet oncology (01.08.2016)
Get full text
Journal Article
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
Lonial, Sagar, Prof, Weiss, Brendan M, Prof, Usmani, Saad Z, Prof, Singhal, Seema, Prof, Chari, Ajai, Prof, Bahlis, Nizar J, Prof, Belch, Andrew, Prof, Krishnan, Amrita, Prof, Vescio, Robert A, Prof, Mateos, Maria Victoria, Prof, Mazumder, Amitabha, Prof, Orlowski, Robert Z, Prof, Sutherland, Heather J, Prof, Bladé, Joan, Prof, Scott, Emma C, Prof, Oriol, Albert, MD, Berdeja, Jesus, MD, Gharibo, Mecide, Prof, Stevens, Don A, MD, LeBlanc, Richard, Prof, Sebag, Michael, Prof, Callander, Natalie, Prof, Jakubowiak, Andrzej, Prof, White, Darrell, Prof, de la Rubia, Javier, Prof, Richardson, Paul G, Prof, Lisby, Steen, MD, Feng, Huaibao, PhD, Uhlar, Clarissa M, PhD, Khan, Imran, MD, Ahmadi, Tahamtan, MD, Voorhees, Peter M, Prof
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
San-Miguel, Jesús F, Prof, Hungria, Vânia T M, MD, Yoon, Sung-Soo, Prof, Beksac, Meral, Prof, Dimopoulos, Meletios Athanasios, Prof, Elghandour, Ashraf, Prof, Jedrzejczak, Wieslaw Wiktor, Prof, Günther, Andreas, MD, Nakorn, Thanyaphong Na, MD, Siritanaratkul, Noppadol, MD, Corradini, Paolo, Prof, Chuncharunee, Suporn, MD, Lee, Je-Jung, Prof, Schlossman, Robert L, MD, Shelekhova, Tatiana, PhD, Yong, Kwee, Prof, Tan, Daryl, MRCP, Numbenjapon, Tontanai, MD, Cavenagh, Jamie D, MD, Hou, Jian, Prof, LeBlanc, Richard, MD, Nahi, Hareth, Prof, Qiu, Lugui, Prof, Salwender, Hans, MD, Pulini, Stefano, MD, Moreau, Philippe, Prof, Warzocha, Krzysztof, Prof, White, Darrell, Prof, Bladé, Joan, MD, Chen, WenMing, Prof, de la Rubia, Javier, Prof, Gimsing, Peter, MD, Lonial, Sagar, Prof, Kaufman, Jonathan L, MD, Ocio, Enrique M, MD, Veskovski, Ljupco, MD, Sohn, Sang Kyun, Prof, Wang, Ming-Chung, MD, Lee, Jae Hoon, Prof, Einsele, Hermann, Prof, Sopala, Monika, PhD, Corrado, Claudia, MD, Bengoudifa, Bourras-Rezki, MS, Binlich, Florence, MD, Richardson, Paul G, Prof
Published in The lancet oncology (01.10.2014)
Published in The lancet oncology (01.10.2014)
Get full text
Journal Article
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Kumar, Shaji K, Prof, Berdeja, Jesus G, MD, Niesvizky, Ruben, Prof, Lonial, Sagar, Prof, Laubach, Jacob P, MD, Hamadani, Mehdi, MD, Stewart, A Keith, Prof, Hari, Parameswaran, Prof, Roy, Vivek, MD, Vescio, Robert, MD, Kaufman, Jonathan L, MD, Berg, Deborah, MSN, Liao, Eileen, PhD, Di Bacco, Alessandra, PhD, Estevam, Jose, BSc, Gupta, Neeraj, PhD, Hui, Ai-Min, MD, Rajkumar, Vincent, Prof, Richardson, Paul G, Prof
Published in The lancet oncology (01.12.2014)
Published in The lancet oncology (01.12.2014)
Get full text
Journal Article
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Yee, Andrew J, MD, Bensinger, William I, MD, Supko, Jeffrey G, PhD, Voorhees, Peter M, MD, Berdeja, Jesus G, MD, Richardson, Paul G, Prof, Libby, Edward N, MD, Wallace, Ellen E, BA, Birrer, Nicole E, BA, Burke, Jill N, MSN, Tamang, David L, PhD, Yang, Min, PhD, Jones, Simon S, PhD, Wheeler, Catherine A, MD, Markelewicz, Robert J, MD, Raje, Noopur S, Dr
Published in The lancet oncology (01.11.2016)
Published in The lancet oncology (01.11.2016)
Get full text
Journal Article
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study
Richardson, Paul G, Jagannath, Sundar, Moreau, Philippe, Jakubowiak, Andrzej J, Raab, Marc S, Facon, Thierry, Vij, Ravi, White, Darrell, Reece, Donna E, Benboubker, Lotfi, Zonder, Jeffrey, Tsao, L Claire, Anderson, Kenneth C, Bleickardt, Eric, Singhal, Anil K, Lonial, Sagar
Published in The Lancet. Haematology (01.12.2015)
Published in The Lancet. Haematology (01.12.2015)
Get more information
Journal Article
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
San-Miguel, Jesús F, Hungria, Vania T M, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A, Elghandour, Ashraf, Jedrzejczak, Wieslaw W, Günther, Andreas, Nakorn, Thanyaphong N, Siritanaratkul, Noppadol, Schlossman, Robert L, Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae H, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Binlich, Florence, Richardson, Paul G
Published in The Lancet. Haematology (01.11.2016)
Published in The Lancet. Haematology (01.11.2016)
Get more information
Journal Article
Role of18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Cavo, Michele, Prof, Terpos, Evangelos, Prof, Nanni, Cristina, MD, Moreau, Philippe, Prof, Lentzsch, Suzanne, MD, Zweegman, Sonja, Prof, Hillengass, Jens, Prof, Engelhardt, Monika, Prof, Usmani, Saad Z, Prof, Vesole, David H, Prof, San-Miguel, Jesus, Prof, Kumar, Shaji K, Prof, Richardson, Paul G, Prof, Mikhael, Joseph R, MD, da Costa, Fernando Leal, MD, Dimopoulos, Meletios-Athanassios, Prof, Zingaretti, Chiara, PhD, Abildgaard, Niels, Prof, Goldschmidt, Hartmut, Prof, Orlowski, Robert Z, Prof, Chng, Wee Joo, Prof, Einsele, Hermann, Prof, Lonial, Sagar, Prof, Barlogie, Bart, Prof, Anderson, Kenneth C, Prof, Rajkumar, S Vincent, Prof, Durie, Brian G M, MD, Zamagni, Elena, MD
Published in The lancet oncology (2017)
Published in The lancet oncology (2017)
Get full text
Journal Article